Mereo BioPharma

Mereo BioPharma is a company listed under the stock ticker MPH (GB).

View the org chart displaying its 18 main executives

Most searched biographies at Mereo BioPharma

• Denise Scots-Knight, Chief Executive Officer and Director
• Anders Ekblom, Non-Executive Director
• Michael Wyzga, Chairman of the Board

Create your alert
to follow the executive moves at Mereo BioPharma.

Mereo BioPharma has 1,869 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Mereo BioPharma

• Corporate Update (1)
• ASBMR Press Release
• Cantor Global Healthcare Conference
• Corporate Update
• Mid Year Financial Results
• Case Studies | Mereo BioPharma
• News | Mereo BioPharma
• Events | Mereo BioPharma
• Press Releases | Mereo BioPharma
• Press Releases | Mereo BioPharma
• View more press releases Close

Social media about Mereo BioPharma

• Mereo BioPharma on Wikipedia, Google News & Yahoo Finance
• Mereo BioPharma on LinkedIn, Twitter & YouTube

Contact by email its executives including Jeremy Bender

Call Mereo BioPharma at +44 333...

View the org chart

Register to receive your alert

Report an error